PatrickJLeaveyMD

Pediatric Hematology & Oncology • Dallas, TX

Professor of Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School

Join to view full profile

Dr. Leavey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Leavey's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-456-2382

Fax+1 214-456-6133

Education & Training

University of ColoradoResidency, Pediatrics, 1996 - 1999
University of ColoradoFellowship, Pediatric Hematology/Oncology, 1992 - 1995
Royal College of Surgeons IrelandClass of 1986

Certifications & Licensure

TX State Medical License 1998 - 2026
CO State Medical License 1995 - 2001
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Start of enrollment: 2012 Aug 01
Completed
Phase 2
Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma Start of enrollment: 2019 Oct 03
Active, not recruiting
Phase 1, Phase 2
Roles: Principal Investigator, Contact
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Start of enrollment: 2016 Nov 02
Recruiting
Phase 2, Phase 3
Roles: Principal Investigator, Contact
Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia Start of enrollment: 2020 Apr 06
Active, not recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

COVID-19 mRNA vaccination responses in individuals with sickle cell disease: an ASH RC Sickle Cell Research Network Study.
Alan R Anderson, John J Strouse, Deepa Manwani, Amanda M Brandow, Elliott Vichinsky
Blood Advances. 2024-09-10
2 citations
Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research.
Donghan M Yang, Qinbo Zhou, Lauren Furman-Cline, Xian Cheng, Danni Luo
JCO Clinical Cancer Informatics. 2023-09-01
4 citations
Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program.
David E Gerber, Jasmin A Tiro, Lorna H McNeill, Erin L Williams, Hong Zhu
Contemporary Clinical Trials. 2022-10-01

Press Mentions

Vignettes of Vermonters Adapting to Life in a PandemicMarch 25th, 2020
Developing a Top-Tier Pediatric Experimental Therapeutics ProgramOctober 10th, 2016
Developing a Top-Tier Pediatric Experimental Therapeutics ProgramOctober 7th, 2016

Grant Support

Metabolic Profiling in Pediatric Fusion Positive SarcomaNIH-NCI Center for Cancer Research2018–2020
Using imaging and computational tools to improve risk stratification in children with bone cancerCancer Prevention and Research Institute of Texas (CPRIT)2015–2019

Professional Memberships

American Academy of Pediatrics - AAP
Fellow
American Society of Pediatric Hematology/Oncology
President